Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes

PURPOSE: Improved understanding of characteristics that may influence treatment response across phenotypes may help guide treatment decisions. PATIENTS AND METHODS: This was a post hoc analysis of MENSA, a multicenter, randomized, double-blind, placebo-controlled trial (NCT01691521). Patients aged ≥...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Asthma Allergy
Autors principals: Prazma, Charlene M, Idzko, Marco, Douglass, Jo Anne, Bourdin, Arnaud, Mallett, Stephen, Albers, Frank C, Yancey, Steven W
Format: Artigo
Idioma:Inglês
Publicat: Dove 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8214022/
https://ncbi.nlm.nih.gov/pubmed/34163180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S298559
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars